Committed to sharing our science

Committed to sharing our science

392 results available

Differences in Healthcare Resource Use and Cost by Treatment Choice Among Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: Real-World Analysis of 2016-2021 Claims Data

Poster, AMCP Nexus 2023
Butzner M, et al.
Orlando, FL
October 17, 2023
A Phase 3 Randomized Controlled Trial Comparing Aficamten Vs Metoprolol In Patients With Symptomatic Hypertrophic Cardiomyopathy And Left Ventricular Outflow Tract Obstruction

Poster, Heart Failure Society of America 2023
Garcia-Pavia P, et al.
Cleveland, OH
October 7, 2023
A Phase 3, Multicenter, Randomized, Double-blind Trial To Evaluate The Efficacy And Safety Of Aficamten Compared To Placebo In Adults With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

Poster, Heart Failure Society of America 2023

Masri A, et al.
Cleveland, OH
October 7, 2023
Cardiovascular Hospitalizations post Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy: A 3-Year Analysis of 5,101 Patients

Poster, Heart Failure Society of America 2023
Altibi A, et al.
Cleveland, OH
October 7, 2023
Symptoms and Complications Significantly Increase the Logistic and Economic Burden of Obstructive Hypertrophic Cardiomyopathy – Results From Medical and Pharmacy Claims Data

Poster, Heart Failure Society of America 2023
Amonkar S, et al.
Cleveland, OH
October 7, 2023